{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/tweet/1341880899428888584","result":{"data":{"site":{"siteMetadata":{"title":"国外股市热门","author":"Buzzing.cc","description":"用中文浏览国外股票社区里的热门讨论","keywords":["buzzing","美股","股票","股市"],"siteUrl":"https://stocks.buzzing.cc","telegram":"@stocks_top","iconUrl":"https://stocks.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Reddit Stocks","url":"https://www.reddit.com/r/stocks","external":true},{"name":"Reddit Investing","url":"https://www.reddit.com/r/investing","external":true},{"name":"Charlie Bilello's twitter","url":"https://twitter.com/charliebilello","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on Stocks","description":"See popular discussions in foreign stock communities in your native language","keywords":["buzzing","stocks","U.S. stocks"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null}]},{"title":"國外股市熱門","description":"用中文瀏覽國外股票社區裡的熱門討論","keywords":["buzzing","美股","股票","股市"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null}]},{"title":"米国株式市場人気の話し合います","description":"人気の米国株式市場の話し合いまを日本語で閲覧","keywords":["buzzing","米国株式市場"],"locale":"ja","social":null,"menuLinks":[]}]}},"blogPost":{"id":"TweetPost-1341880899428888584","excerpt":"","body":"","slug":"/tweet/1341880899428888584","title":"Tech leading all S&amp;P 500 sectors for the 2nd year in a row with a 43% gain.\n\nFollowing the 50% gain in 2019 this the 2nd best 2-year performance ever for Tech after 1998-1999.\n\n$XLK\n\nData via @ycharts https://t.co/Jo1z8zkBsw","tags":["tweet"],"date":"December 24, 2020","dateISO":"2020-12-24T12:35:30.000Z","datetime":"2020-12-24 12:35","image":null,"imageAlt":"Tweet Image","socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"1341880899428888584","provider":"Twitter","url":"https://twitter.com/charliebilello/statuses/1341880899428888584","originalUrl":null,"imageRemote":"https://pbs.twimg.com/media/Ep9RVqzXUAMzrWi.png","video":null,"channel":null,"channelUrl":null,"author":"Charlie Bilello","authorUrl":"https://twitter.com/charliebilello","authorImage":null,"authorImageRemote":"https://pbs.twimg.com/profile_images/1207655488168574976/N0sQdj76.png","authorSlug":"charliebilello","score":433,"views":null,"sharedCount":87,"likeCount":259,"sharedContent":null,"parent":{"localize":[{"locale":"zh","full_text":"科技股以43%的涨幅连续第二年领跑所有标准普尔500指数板块。\n\n继2019年增长50%之后，这是Tech在1998-1999年后第二好的两年表现。\n\n$XLK\n\n通过@ycharts https://t.co/Jo1z8zkBsw提供的数据","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"科技股以43%的漲幅連續第二年領跑所有標準普爾500指數板塊。\n\n繼2019年增長50%之後，這是Tech在1998-1999年後第二好的兩年表現。\n\n$XLK\n\n通過@ycharts https://t.co/Jo1z8zkBsw提供的數據","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"previous":{"id":"TweetPost-1341931475260895236","excerpt":"","slug":"/tweet/1341931475260895236","title":"A Short History of Chasing the Best Performing Funds\n\nThis one is for all the new ARKK shareholders\n\nhttps://t.co/gvF4Q7HzGx","date":"December 24, 2020","__typename":"SocialMediaPost","parent":{"localize":[{"locale":"zh","full_text":"追逐业绩最佳基金简史\n\n这是献给方舟的所有新股东\n\nhttps://t.co/gvF4Q7HzGx","quoted_status_full_text":null,"retweeted_status_full_text":null},{"locale":"zh-Hant","full_text":"追逐業績最佳基金簡史\n\n這是獻給方舟的所有新股東\n\nhttps://t.co/gvF4Q7HzGx","quoted_status_full_text":null,"retweeted_status_full_text":null}]}},"next":{"id":"RedditPost-ac97c95b-c7f6-5412-a5ce-8cebbfa5eda6","excerpt":"Just released!\n\n * 100% cellular response in the 2 mg group\n * Grade 1 adverse side effects = Redness at injection site/erythema\n\nhttps://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext\n[https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20]30433-8/fulltext)","slug":"/reddit/r/stocks/comments/kjexi6/inovio_pharmaceuticals_ino4800_peer_review/","title":"Inovio Pharmaceuticals INO-4800 Peer Review Released. 100% Efficacy.","__typename":"SocialMediaPost","date":"December 24, 2020","parent":{"localize":[{"title":"Inovio制药INO-4800同行评审发布。100%有效率。","the_new_excerpt":"刚刚被释放！\n\n*2毫克组细胞反应率为100%\n*一级不良反应=注射部位发红/红斑\n\nhttps://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext\n[https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20]30433-8/fulltext)","locale":"zh"},{"title":"Inovio製藥INO-4800同行評審發佈。100%有效率。","the_new_excerpt":"剛剛被釋放！\n\n*2毫克組細胞反應率爲100%\n*一級不良反應=注射部位發紅/紅斑\n\nhttps://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30433-8/fulltext\n[https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20]30433-8/fulltext)","locale":"zh-Hant"}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"TweetPost-1341880899428888584","previousId":"TweetPost-1341931475260895236","nextId":"RedditPost-ac97c95b-c7f6-5412-a5ce-8cebbfa5eda6","maxWidth":1024,"siteMetadata":null,"locale":"zh","hrefLang":"zh-Hans","originalPath":"/tweet/1341880899428888584","dateFormat":"YYYY-MM-DD"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}